nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—DRD4—conduct disorder	0.597	0.684	CbGaD
Pergolide—HTR2A—conduct disorder	0.275	0.316	CbGaD
Pergolide—Cabergoline—DRD4—conduct disorder	0.0026	0.345	CrCbGaD
Pergolide—Lisuride—DRD4—conduct disorder	0.00174	0.231	CrCbGaD
Pergolide—Cabergoline—HTR2A—conduct disorder	0.0012	0.159	CrCbGaD
Pergolide—Methylergometrine—HTR2A—conduct disorder	0.0012	0.159	CrCbGaD
Pergolide—Lisuride—HTR2A—conduct disorder	0.000804	0.107	CrCbGaD
Pergolide—HTR2A—autonomic nervous system—conduct disorder	0.000464	0.21	CbGeAlD
Pergolide—DRD4—brain—conduct disorder	0.000229	0.104	CbGeAlD
Pergolide—DRD3—brain—conduct disorder	0.000161	0.0729	CbGeAlD
Pergolide—DRD5—brain—conduct disorder	0.000151	0.0683	CbGeAlD
Pergolide—ADRA1B—brain—conduct disorder	0.000123	0.056	CbGeAlD
Pergolide—ADRA1D—brain—conduct disorder	0.000121	0.0548	CbGeAlD
Pergolide—DRD1—brain—conduct disorder	0.000115	0.0522	CbGeAlD
Pergolide—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000114	0.000975	CbGpPWpGaD
Pergolide—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000114	0.000972	CbGpPWpGaD
Pergolide—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000114	0.000967	CbGpPWpGaD
Pergolide—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000113	0.000961	CbGpPWpGaD
Pergolide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00011	0.000939	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—CGA—conduct disorder	0.00011	0.000936	CbGpPWpGaD
Pergolide—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000109	0.000928	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.000108	0.000923	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000108	0.000923	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.000918	CbGpPWpGaD
Pergolide—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000107	0.000909	CbGpPWpGaD
Pergolide—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.000909	CbGpPWpGaD
Pergolide—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000106	0.000906	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000104	0.000886	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000103	0.000881	CbGpPWpGaD
Pergolide—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000103	0.000878	CbGpPWpGaD
Pergolide—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000103	0.000878	CbGpPWpGaD
Pergolide—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000103	0.000875	CbGpPWpGaD
Pergolide—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000103	0.000873	CbGpPWpGaD
Pergolide—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000103	0.000873	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—DRD4—conduct disorder	0.000102	0.000868	CbGpPWpGaD
Pergolide—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000101	0.000863	CbGpPWpGaD
Pergolide—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000101	0.000863	CbGpPWpGaD
Pergolide—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000101	0.000859	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.000101	0.000857	CbGpPWpGaD
Pergolide—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.97e-05	0.00085	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	9.97e-05	0.000849	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	9.9e-05	0.000844	CbGpPWpGaD
Pergolide—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.81e-05	0.000836	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	9.81e-05	0.000836	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—CGA—conduct disorder	9.78e-05	0.000833	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CGA—conduct disorder	9.76e-05	0.000832	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CGA—conduct disorder	9.44e-05	0.000804	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CGA—conduct disorder	9.39e-05	0.0008	CbGpPWpGaD
Pergolide—HTR1B—brain—conduct disorder	9.32e-05	0.0423	CbGeAlD
Pergolide—DRD5—Signaling by GPCR—DRD4—conduct disorder	9.26e-05	0.000789	CbGpPWpGaD
Pergolide—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.15e-05	0.000779	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CGA—conduct disorder	9.14e-05	0.000778	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CGA—conduct disorder	9.13e-05	0.000778	CbGpPWpGaD
Pergolide—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.05e-05	0.000771	CbGpPWpGaD
Pergolide—DRD2—GPCR ligand binding—DRD4—conduct disorder	9.05e-05	0.000771	CbGpPWpGaD
Pergolide—HTR1D—brain—conduct disorder	9.03e-05	0.041	CbGeAlD
Pergolide—CYP2D6—Biological oxidations—COMT—conduct disorder	9.02e-05	0.000768	CbGpPWpGaD
Pergolide—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	9.01e-05	0.000768	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CGA—conduct disorder	8.99e-05	0.000766	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.98e-05	0.000765	CbGpPWpGaD
Pergolide—CYP2D6—Biological oxidations—MAOA—conduct disorder	8.95e-05	0.000763	CbGpPWpGaD
Pergolide—HTR2C—brain—conduct disorder	8.94e-05	0.0406	CbGeAlD
Pergolide—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.9e-05	0.000758	CbGpPWpGaD
Pergolide—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	8.89e-05	0.000758	CbGpPWpGaD
Pergolide—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.83e-05	0.000752	CbGpPWpGaD
Pergolide—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	8.83e-05	0.000752	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.8e-05	0.000749	CbGpPWpGaD
Pergolide—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.78e-05	0.000748	CbGpPWpGaD
Pergolide—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.72e-05	0.000743	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	8.72e-05	0.000743	CbGpPWpGaD
Pergolide—DRD4—GPCR ligand binding—HTR2A—conduct disorder	8.68e-05	0.00074	CbGpPWpGaD
Pergolide—DRD4—Circadian rythm related genes—EP300—conduct disorder	8.61e-05	0.000734	CbGpPWpGaD
Pergolide—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.54e-05	0.000728	CbGpPWpGaD
Pergolide—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.41e-05	0.000716	CbGpPWpGaD
Pergolide—HTR2B—brain—conduct disorder	8.4e-05	0.0381	CbGeAlD
Pergolide—DRD2—Signaling by GPCR—CGA—conduct disorder	8.29e-05	0.000706	CbGpPWpGaD
Pergolide—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	8.29e-05	0.000706	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8.17e-05	0.000696	CbGpPWpGaD
Pergolide—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.16e-05	0.000696	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.16e-05	0.000695	CbGpPWpGaD
Pergolide—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.1e-05	0.00069	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	8.1e-05	0.00069	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.99e-05	0.000681	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—WASF1—conduct disorder	7.82e-05	0.000667	CbGpPWpGaD
Pergolide—DRD1—GPCR ligand binding—HTR2A—conduct disorder	7.82e-05	0.000666	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.81e-05	0.000665	CbGpPWpGaD
Pergolide—DRD1—Circadian rythm related genes—EP300—conduct disorder	7.75e-05	0.00066	CbGpPWpGaD
Pergolide—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.75e-05	0.00066	CbGpPWpGaD
Pergolide—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.71e-05	0.000657	CbGpPWpGaD
Pergolide—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.71e-05	0.000657	CbGpPWpGaD
Pergolide—DRD3—Circadian rythm related genes—EP300—conduct disorder	7.65e-05	0.000652	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	7.64e-05	0.000651	CbGpPWpGaD
Pergolide—HTR1A—brain—conduct disorder	7.53e-05	0.0341	CbGeAlD
Pergolide—HTR1D—Signaling Pathways—CGA—conduct disorder	7.48e-05	0.000637	CbGpPWpGaD
Pergolide—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.47e-05	0.000636	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.42e-05	0.000632	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CGA—conduct disorder	7.32e-05	0.000624	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CGA—conduct disorder	7.21e-05	0.000614	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	7.18e-05	0.000612	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—DRD4—conduct disorder	7.09e-05	0.000604	CbGpPWpGaD
Pergolide—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.05e-05	0.000601	CbGpPWpGaD
Pergolide—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.96e-05	0.000593	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—DRD4—conduct disorder	6.94e-05	0.000591	CbGpPWpGaD
Pergolide—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.94e-05	0.000591	CbGpPWpGaD
Pergolide—ADRA1A—brain—conduct disorder	6.94e-05	0.0315	CbGeAlD
Pergolide—HTR2B—Signaling Pathways—CGA—conduct disorder	6.88e-05	0.000586	CbGpPWpGaD
Pergolide—DRD2—brain—conduct disorder	6.8e-05	0.0308	CbGeAlD
Pergolide—DRD1—GPCR downstream signaling—DRD4—conduct disorder	6.77e-05	0.000577	CbGpPWpGaD
Pergolide—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.72e-05	0.000573	CbGpPWpGaD
Pergolide—KCNH2—brain—conduct disorder	6.7e-05	0.0304	CbGeAlD
Pergolide—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.69e-05	0.00057	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.68e-05	0.000569	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.68e-05	0.000569	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	6.65e-05	0.000567	CbGpPWpGaD
Pergolide—ADRA2C—brain—conduct disorder	6.61e-05	0.03	CbGeAlD
Pergolide—HTR2B—Signaling by GPCR—DRD4—conduct disorder	6.52e-05	0.000556	CbGpPWpGaD
Pergolide—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.51e-05	0.000554	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CGA—conduct disorder	6.49e-05	0.000553	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—CGA—conduct disorder	6.45e-05	0.00055	CbGpPWpGaD
Pergolide—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	6.4e-05	0.000545	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CGA—conduct disorder	6.4e-05	0.000545	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CGA—conduct disorder	6.4e-05	0.000545	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—DRD4—conduct disorder	6.15e-05	0.000524	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—DRD4—conduct disorder	6.07e-05	0.000517	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	6.07e-05	0.000517	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—HTR2A—conduct disorder	6.04e-05	0.000514	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	6.03e-05	0.000514	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—WASF1—conduct disorder	5.99e-05	0.000511	CbGpPWpGaD
Pergolide—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.9e-05	0.000503	CbGpPWpGaD
Pergolide—CYP3A4—Biological oxidations—COMT—conduct disorder	5.9e-05	0.000502	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—WASF1—conduct disorder	5.87e-05	0.0005	CbGpPWpGaD
Pergolide—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.85e-05	0.000499	CbGpPWpGaD
Pergolide—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.85e-05	0.000499	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.82e-05	0.000496	CbGpPWpGaD
Pergolide—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.82e-05	0.000495	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.79e-05	0.000494	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.78e-05	0.000492	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—WASF1—conduct disorder	5.77e-05	0.000492	CbGpPWpGaD
Pergolide—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.69e-05	0.000485	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.63e-05	0.00048	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CGA—conduct disorder	5.58e-05	0.000475	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CGA—conduct disorder	5.55e-05	0.000473	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.55e-05	0.000472	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.51e-05	0.00047	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.48e-05	0.000467	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—DRD4—conduct disorder	5.47e-05	0.000466	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.4e-05	0.00046	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CGA—conduct disorder	5.31e-05	0.000453	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.29e-05	0.000451	CbGpPWpGaD
Pergolide—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.28e-05	0.00045	CbGpPWpGaD
Pergolide—ADRA2A—brain—conduct disorder	5.27e-05	0.0239	CbGeAlD
Pergolide—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.26e-05	0.000448	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CGA—conduct disorder	5.24e-05	0.000447	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—WASF1—conduct disorder	5.2e-05	0.000443	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—WASF1—conduct disorder	5.13e-05	0.000437	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—WASF1—conduct disorder	5.13e-05	0.000437	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.12e-05	0.000436	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.11e-05	0.000436	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	5.09e-05	0.000434	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	5.04e-05	0.000429	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.03e-05	0.000429	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	4.99e-05	0.000425	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.93e-05	0.00042	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.91e-05	0.000418	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CGA—conduct disorder	4.9e-05	0.000417	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CGA—conduct disorder	4.82e-05	0.000411	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.72e-05	0.000402	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.69e-05	0.000399	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.64e-05	0.000396	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.63e-05	0.000395	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.63e-05	0.000394	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.58e-05	0.00039	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.57e-05	0.000389	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.53e-05	0.000386	CbGpPWpGaD
Pergolide—HTR2A—brain—conduct disorder	4.48e-05	0.0203	CbGeAlD
Pergolide—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.47e-05	0.000381	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.47e-05	0.000381	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.46e-05	0.00038	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.45e-05	0.000379	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.42e-05	0.000376	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.38e-05	0.000374	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	4.36e-05	0.000371	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.36e-05	0.000371	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.33e-05	0.000369	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—WASF1—conduct disorder	4.26e-05	0.000363	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	4.25e-05	0.000362	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—DRD4—conduct disorder	4.19e-05	0.000357	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.16e-05	0.000354	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—DRD4—conduct disorder	4.1e-05	0.000349	CbGpPWpGaD
Pergolide—CYP2D6—brain—conduct disorder	4.09e-05	0.0185	CbGeAlD
Pergolide—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.01e-05	0.000342	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.96e-05	0.000337	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.96e-05	0.000337	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.94e-05	0.000335	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—WASF1—conduct disorder	3.92e-05	0.000334	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.86e-05	0.000329	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.85e-05	0.000328	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.8e-05	0.000324	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.78e-05	0.000322	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.78e-05	0.000322	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.68e-05	0.000313	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—DRD4—conduct disorder	3.63e-05	0.000309	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.62e-05	0.000308	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—DRD4—conduct disorder	3.58e-05	0.000305	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.58e-05	0.000305	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.57e-05	0.000305	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—HTR2A—conduct disorder	3.57e-05	0.000304	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.51e-05	0.000299	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.45e-05	0.000294	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.43e-05	0.000292	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CGA—conduct disorder	3.42e-05	0.000291	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.34e-05	0.000284	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.34e-05	0.000284	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—EP300—conduct disorder	3.3e-05	0.000281	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.29e-05	0.00028	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.24e-05	0.000276	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	3.21e-05	0.000274	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.12e-05	0.000266	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.11e-05	0.000265	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—EP300—conduct disorder	3.08e-05	0.000263	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.03e-05	0.000258	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—DRD4—conduct disorder	3.02e-05	0.000258	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.99e-05	0.000254	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.97e-05	0.000253	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.92e-05	0.000249	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—COMT—conduct disorder	2.91e-05	0.000248	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—MAOA—conduct disorder	2.89e-05	0.000247	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—DRD4—conduct disorder	2.74e-05	0.000234	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.73e-05	0.000233	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.71e-05	0.000231	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.7e-05	0.00023	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.68e-05	0.000228	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.64e-05	0.000225	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.63e-05	0.000224	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.51e-05	0.000214	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—EP300—conduct disorder	2.5e-05	0.000213	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.46e-05	0.000209	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.37e-05	0.000202	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—COMT—conduct disorder	2.37e-05	0.000202	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—MAOA—conduct disorder	2.35e-05	0.0002	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.34e-05	0.000199	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.34e-05	0.000199	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CGA—conduct disorder	2.23e-05	0.00019	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.11e-05	0.00018	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.04e-05	0.000174	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.03e-05	0.000173	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.97e-05	0.000168	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.94e-05	0.000165	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—EP300—conduct disorder	1.89e-05	0.000161	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.79e-05	0.000152	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.72e-05	0.000147	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.6e-05	0.000136	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—COMT—conduct disorder	1.54e-05	0.000131	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—MAOA—conduct disorder	1.53e-05	0.00013	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EP300—conduct disorder	1.45e-05	0.000123	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EP300—conduct disorder	1.42e-05	0.000121	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EP300—conduct disorder	1.39e-05	0.000119	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000113	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EP300—conduct disorder	1.26e-05	0.000107	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—EP300—conduct disorder	1.25e-05	0.000106	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.24e-05	0.000106	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EP300—conduct disorder	1.24e-05	0.000106	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.12e-05	9.53e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EP300—conduct disorder	1.08e-05	9.2e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EP300—conduct disorder	1.07e-05	9.15e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.04e-05	8.9e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.03e-05	8.76e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—EP300—conduct disorder	1.01e-05	8.65e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—COMT—conduct disorder	1.01e-05	8.59e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MAOA—conduct disorder	1e-05	8.53e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EP300—conduct disorder	9.48e-06	8.08e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EP300—conduct disorder	9.33e-06	7.95e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EP300—conduct disorder	9.13e-06	7.78e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.49e-06	7.23e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—EP300—conduct disorder	6.61e-06	5.63e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—EP300—conduct disorder	4.32e-06	3.68e-05	CbGpPWpGaD
